779 related articles for article (PubMed ID: 36835352)
1. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
2. Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.
Song M; He J; Pan QZ; Yang J; Zhao J; Zhang YJ; Huang Y; Tang Y; Wang Q; He J; Gu J; Li Y; Chen S; Zeng J; Zhou ZQ; Yang C; Han Y; Chen H; Xiang T; Weng DS; Xia JC
Hepatology; 2021 May; 73(5):1717-1735. PubMed ID: 33682185
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma cells remodel the pro-metastatic tumour microenvironment through recruitment and activation of fibroblasts via paracrine Egfl7 signaling.
Sun B; Lei X; Cao M; Li Y; Yang LY
Cell Commun Signal; 2023 Jul; 21(1):180. PubMed ID: 37480091
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
6. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
Yin Z; Dong C; Jiang K; Xu Z; Li R; Guo K; Shao S; Wang L
J Hematol Oncol; 2019 Sep; 12(1):101. PubMed ID: 31547836
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in hepatocellular carcinoma.
Kubo N; Araki K; Kuwano H; Shirabe K
World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts induce immunotherapy resistance in hepatocellular carcinoma animal model.
Yu L; Liu Q; Huo J; Wei F; Guo W
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):36-40. PubMed ID: 32415924
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.
Ying F; Chan MSM; Lee TKW
Cell Mol Gastroenterol Hepatol; 2023; 15(4):985-999. PubMed ID: 36708970
[TBL] [Abstract][Full Text] [Related]
14. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.
Zheng X; Xu M; Yao B; Wang C; Jia Y; Liu Q
Cell Signal; 2016 Sep; 28(9):1314-1324. PubMed ID: 27297362
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
16. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
Baglieri J; Brenner DA; Kisseleva T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated Fibroblasts induce epithelial-mesenchymal transition
Jia C; Wang G; Wang T; Fu B; Zhang Y; Huang L; Deng Y; Chen G; Wu X; Chen J; Pan Y; Tai Y; Liang J; Li X; Hu K; Xie B; Li S; Yang Y; Chen G; Zhang Q; Liu W
Int J Biol Sci; 2020; 16(14):2542-2558. PubMed ID: 32792856
[TBL] [Abstract][Full Text] [Related]
18. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming.
Wang H; Liu F; Wu X; Zhu G; Tang Z; Qu W; Zhao Q; Huang R; Tian M; Fang Y; Jiang X; Tao C; Gao J; Liu W; Zhou J; Fan J; Wu D; Shi Y
Exp Cell Res; 2024 Feb; 435(2):113947. PubMed ID: 38301989
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma.
Cheng Y; Li H; Deng Y; Tai Y; Zeng K; Zhang Y; Liu W; Zhang Q; Yang Y
Cell Death Dis; 2018 Apr; 9(4):422. PubMed ID: 29556041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
